Clene, Inc. (CLNN)
4.16
+0.06
(+1.34%)
USD |
NASDAQ |
Sep 02, 16:00
4.19
+0.03
(+0.72%)
After-Hours: 20:00
Clene Cash from Investing (Quarterly) : -0.001M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.001M |
| March 31, 2026 | 0.00 |
| December 31, 2025 | -0.0281M |
| September 30, 2025 | -0.011M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.0105M |
| September 30, 2024 | 0.0082M |
| June 30, 2024 | 6.249M |
| March 31, 2024 | 0.071M |
| December 31, 2023 | -6.218M |
| September 30, 2023 | -0.0449M |
| June 30, 2023 | 0.0388M |
| March 31, 2023 | 4.722M |
| December 31, 2022 | 2.241M |
| September 30, 2022 | 8.386M |
| June 30, 2022 | 3.720M |
| Date | Value |
|---|---|
| March 31, 2022 | -24.52M |
| December 31, 2021 | -0.6692M |
| September 30, 2021 | -0.2401M |
| June 30, 2021 | -0.2168M |
| March 31, 2021 | -0.203M |
| December 31, 2020 | -0.3872M |
| September 30, 2020 | -0.0752M |
| June 30, 2020 | -0.1712M |
| March 31, 2020 | -0.023M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.0928M |
| September 30, 2018 | -45.96M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| NovelStem International Corp. | 0.00 |
| Brainstorm Cell Therapeutics, Inc. | 0.00 |
| Summit Therapeutics, Inc. | 222.41M |
| Kezar Life Sciences, Inc. | 1.529M |
| Protara Therapeutics, Inc. | 17.75M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.578M |
| Cash from Financing (Quarterly) | 6.313M |
| Free Cash Flow | -16.00M |
| Free Cash Flow Per Share (Quarterly) | -0.2083 |
| Free Cash Flow to Equity (Quarterly) | -2.875M |
| Free Cash Flow to Firm (Quarterly) | -1.884M |
| Free Cash Flow Yield | -34.34% |